Loading…

Involvement of the Lateral Amygdala in the Antiallodynic and Reinforcing Effects of Heroin in Rats after Peripheral Nerve Injury

Neuropathic pain alters opioid self-administration in rats. The brain regions altered in the presence of neuropathic pain mediating these differences have not been identified, but likely involve ascending pain pathways interacting with the limbic system. The amygdala is a brain region that integrate...

Full description

Saved in:
Bibliographic Details
Published in:Anesthesiology (Philadelphia) 2011-03, Vol.114 (3), p.633-642
Main Authors: MARTIN, Thomas J, BUECHLER, Nancy L, KIM, Susy A, EWAN, Eric E, RUOYU XIAO, CHILDERS, Steven R
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c535t-5cd2e15ee6489581b10a28224ccda02763c5c1122c65b457db09f0c05d9c58303
cites
container_end_page 642
container_issue 3
container_start_page 633
container_title Anesthesiology (Philadelphia)
container_volume 114
creator MARTIN, Thomas J
BUECHLER, Nancy L
KIM, Susy A
EWAN, Eric E
RUOYU XIAO
CHILDERS, Steven R
description Neuropathic pain alters opioid self-administration in rats. The brain regions altered in the presence of neuropathic pain mediating these differences have not been identified, but likely involve ascending pain pathways interacting with the limbic system. The amygdala is a brain region that integrates noxious stimulation with limbic activity. μ-Opioid receptors were blocked in the amygdala using the irreversible antagonist, β-funaltrexamine, and the antiallodynic and reinforcing effects of heroin were determined in spinal nerve-ligated rats. In addition, the effect of β-funaltrexamine was determined on heroin self-administration in sham-operated rats. β-Funaltrexamine decreased functional activity of μ-opioid receptors by 60 ± 5% (mean ± SD). Irreversible inhibition of μ-opioid receptors in the amygdala significantly attenuated the ability of doses of heroin up to 100 μg/kg to reverse hypersensitivity after spinal nerve ligation. Heroin intake by self-administration in spinal nerve-ligated rats was increased from 5.0 ± 0.3 to 9.9 ± 2.1 infusions/h after administration of 2.5 nmol of β-funaltrexamine in the lateral amygdala, while having no effect in sham-operated animals (5.8 ± 1.6 before, 6.7 ± 0.9 after). The antiallodynic effects of 60 μg/kg heroin were decreased up to 4 days, but self-administration was affected for up to 14 days. μ-Opioid receptors in the lateral amygdala partially meditate heroin's antiallodynic effects and self-administration after peripheral nerve injury. The lack of effect of β-funaltrexamine on heroin self-administration in sham-operated subjects suggests that opioids maintain self-administration through a distinct mechanism in the presence of pain.
doi_str_mv 10.1097/aln.0b013e318209aba7
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3044784</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>923201779</sourcerecordid><originalsourceid>FETCH-LOGICAL-c535t-5cd2e15ee6489581b10a28224ccda02763c5c1122c65b457db09f0c05d9c58303</originalsourceid><addsrcrecordid>eNpdkV9rFDEUxYModq1-A5G8SJ-m5s9kk7wIS6l2YalS9DncyWR2UzLJmswu7Jsf3bRd2yoEQm7O-d17OQi9p-ScEi0_QYjnpCOUO04VIxo6kC_QjAqmGkqleIlmhBDecMLYCXpTym19SsHVa3TCKNOcCTFDv5dxn8LejS5OOA142ji8gsllCHgxHtY9BMA-3tcXcfIQQuoP0VsMscc3zschZevjGl8Og7NTuYNcuZyqp54bqBUYKg9_d9lvN_fga5f3Di_j7S4f3qJXA4Ti3h3vU_Tzy-WPi6tm9e3r8mKxaqzgYmqE7Zmjwrl5q7RQtKMEmGKstbYHwuScW2EpZczORdcK2XdED8QS0WsrFCf8FH1-4G533eh6W_eto5ht9iPkg0ngzb8_0W_MOu0NJ20rVVsBZ0dATr92rkxm9MW6ECC6tCtGM84IlVJXZfugtDmVkt3w2IUSc5edWayuzf_ZVduH5xM-mv6GVQUfjwIoFsKQIVpfnnRcKa2V5H8A3Bqlpw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>923201779</pqid></control><display><type>article</type><title>Involvement of the Lateral Amygdala in the Antiallodynic and Reinforcing Effects of Heroin in Rats after Peripheral Nerve Injury</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><creator>MARTIN, Thomas J ; BUECHLER, Nancy L ; KIM, Susy A ; EWAN, Eric E ; RUOYU XIAO ; CHILDERS, Steven R</creator><creatorcontrib>MARTIN, Thomas J ; BUECHLER, Nancy L ; KIM, Susy A ; EWAN, Eric E ; RUOYU XIAO ; CHILDERS, Steven R</creatorcontrib><description>Neuropathic pain alters opioid self-administration in rats. The brain regions altered in the presence of neuropathic pain mediating these differences have not been identified, but likely involve ascending pain pathways interacting with the limbic system. The amygdala is a brain region that integrates noxious stimulation with limbic activity. μ-Opioid receptors were blocked in the amygdala using the irreversible antagonist, β-funaltrexamine, and the antiallodynic and reinforcing effects of heroin were determined in spinal nerve-ligated rats. In addition, the effect of β-funaltrexamine was determined on heroin self-administration in sham-operated rats. β-Funaltrexamine decreased functional activity of μ-opioid receptors by 60 ± 5% (mean ± SD). Irreversible inhibition of μ-opioid receptors in the amygdala significantly attenuated the ability of doses of heroin up to 100 μg/kg to reverse hypersensitivity after spinal nerve ligation. Heroin intake by self-administration in spinal nerve-ligated rats was increased from 5.0 ± 0.3 to 9.9 ± 2.1 infusions/h after administration of 2.5 nmol of β-funaltrexamine in the lateral amygdala, while having no effect in sham-operated animals (5.8 ± 1.6 before, 6.7 ± 0.9 after). The antiallodynic effects of 60 μg/kg heroin were decreased up to 4 days, but self-administration was affected for up to 14 days. μ-Opioid receptors in the lateral amygdala partially meditate heroin's antiallodynic effects and self-administration after peripheral nerve injury. The lack of effect of β-funaltrexamine on heroin self-administration in sham-operated subjects suggests that opioids maintain self-administration through a distinct mechanism in the presence of pain.</description><identifier>ISSN: 0003-3022</identifier><identifier>EISSN: 1528-1175</identifier><identifier>DOI: 10.1097/aln.0b013e318209aba7</identifier><identifier>PMID: 21293255</identifier><identifier>CODEN: ANESAV</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Amygdala - physiology ; Analgesics, Opioid - pharmacology ; Anesthesia ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Behavior, Animal - drug effects ; Biological and medical sciences ; Brain - drug effects ; Brain - metabolism ; Conditioning, Operant - drug effects ; Enkephalin, Ala-MePhe-Gly- - pharmacology ; Guanosine 5'-O-(3-Thiotriphosphate) - metabolism ; Heroin - pharmacology ; Hyperalgesia - drug therapy ; Hyperalgesia - psychology ; Infusions, Intravenous ; Male ; Medical sciences ; Naltrexone - analogs &amp; derivatives ; Naltrexone - pharmacology ; Narcotic Antagonists - pharmacology ; Peripheral Nerve Injuries ; Rats ; Rats, Inbred F344 ; Reinforcement, Psychology ; Self Administration ; Spinal Nerves - injuries</subject><ispartof>Anesthesiology (Philadelphia), 2011-03, Vol.114 (3), p.633-642</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c535t-5cd2e15ee6489581b10a28224ccda02763c5c1122c65b457db09f0c05d9c58303</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23889987$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21293255$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MARTIN, Thomas J</creatorcontrib><creatorcontrib>BUECHLER, Nancy L</creatorcontrib><creatorcontrib>KIM, Susy A</creatorcontrib><creatorcontrib>EWAN, Eric E</creatorcontrib><creatorcontrib>RUOYU XIAO</creatorcontrib><creatorcontrib>CHILDERS, Steven R</creatorcontrib><title>Involvement of the Lateral Amygdala in the Antiallodynic and Reinforcing Effects of Heroin in Rats after Peripheral Nerve Injury</title><title>Anesthesiology (Philadelphia)</title><addtitle>Anesthesiology</addtitle><description>Neuropathic pain alters opioid self-administration in rats. The brain regions altered in the presence of neuropathic pain mediating these differences have not been identified, but likely involve ascending pain pathways interacting with the limbic system. The amygdala is a brain region that integrates noxious stimulation with limbic activity. μ-Opioid receptors were blocked in the amygdala using the irreversible antagonist, β-funaltrexamine, and the antiallodynic and reinforcing effects of heroin were determined in spinal nerve-ligated rats. In addition, the effect of β-funaltrexamine was determined on heroin self-administration in sham-operated rats. β-Funaltrexamine decreased functional activity of μ-opioid receptors by 60 ± 5% (mean ± SD). Irreversible inhibition of μ-opioid receptors in the amygdala significantly attenuated the ability of doses of heroin up to 100 μg/kg to reverse hypersensitivity after spinal nerve ligation. Heroin intake by self-administration in spinal nerve-ligated rats was increased from 5.0 ± 0.3 to 9.9 ± 2.1 infusions/h after administration of 2.5 nmol of β-funaltrexamine in the lateral amygdala, while having no effect in sham-operated animals (5.8 ± 1.6 before, 6.7 ± 0.9 after). The antiallodynic effects of 60 μg/kg heroin were decreased up to 4 days, but self-administration was affected for up to 14 days. μ-Opioid receptors in the lateral amygdala partially meditate heroin's antiallodynic effects and self-administration after peripheral nerve injury. The lack of effect of β-funaltrexamine on heroin self-administration in sham-operated subjects suggests that opioids maintain self-administration through a distinct mechanism in the presence of pain.</description><subject>Amygdala - physiology</subject><subject>Analgesics, Opioid - pharmacology</subject><subject>Anesthesia</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Biological and medical sciences</subject><subject>Brain - drug effects</subject><subject>Brain - metabolism</subject><subject>Conditioning, Operant - drug effects</subject><subject>Enkephalin, Ala-MePhe-Gly- - pharmacology</subject><subject>Guanosine 5'-O-(3-Thiotriphosphate) - metabolism</subject><subject>Heroin - pharmacology</subject><subject>Hyperalgesia - drug therapy</subject><subject>Hyperalgesia - psychology</subject><subject>Infusions, Intravenous</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Naltrexone - analogs &amp; derivatives</subject><subject>Naltrexone - pharmacology</subject><subject>Narcotic Antagonists - pharmacology</subject><subject>Peripheral Nerve Injuries</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Reinforcement, Psychology</subject><subject>Self Administration</subject><subject>Spinal Nerves - injuries</subject><issn>0003-3022</issn><issn>1528-1175</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNpdkV9rFDEUxYModq1-A5G8SJ-m5s9kk7wIS6l2YalS9DncyWR2UzLJmswu7Jsf3bRd2yoEQm7O-d17OQi9p-ScEi0_QYjnpCOUO04VIxo6kC_QjAqmGkqleIlmhBDecMLYCXpTym19SsHVa3TCKNOcCTFDv5dxn8LejS5OOA142ji8gsllCHgxHtY9BMA-3tcXcfIQQuoP0VsMscc3zschZevjGl8Og7NTuYNcuZyqp54bqBUYKg9_d9lvN_fga5f3Di_j7S4f3qJXA4Ti3h3vU_Tzy-WPi6tm9e3r8mKxaqzgYmqE7Zmjwrl5q7RQtKMEmGKstbYHwuScW2EpZczORdcK2XdED8QS0WsrFCf8FH1-4G533eh6W_eto5ht9iPkg0ngzb8_0W_MOu0NJ20rVVsBZ0dATr92rkxm9MW6ECC6tCtGM84IlVJXZfugtDmVkt3w2IUSc5edWayuzf_ZVduH5xM-mv6GVQUfjwIoFsKQIVpfnnRcKa2V5H8A3Bqlpw</recordid><startdate>20110301</startdate><enddate>20110301</enddate><creator>MARTIN, Thomas J</creator><creator>BUECHLER, Nancy L</creator><creator>KIM, Susy A</creator><creator>EWAN, Eric E</creator><creator>RUOYU XIAO</creator><creator>CHILDERS, Steven R</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20110301</creationdate><title>Involvement of the Lateral Amygdala in the Antiallodynic and Reinforcing Effects of Heroin in Rats after Peripheral Nerve Injury</title><author>MARTIN, Thomas J ; BUECHLER, Nancy L ; KIM, Susy A ; EWAN, Eric E ; RUOYU XIAO ; CHILDERS, Steven R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c535t-5cd2e15ee6489581b10a28224ccda02763c5c1122c65b457db09f0c05d9c58303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Amygdala - physiology</topic><topic>Analgesics, Opioid - pharmacology</topic><topic>Anesthesia</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Biological and medical sciences</topic><topic>Brain - drug effects</topic><topic>Brain - metabolism</topic><topic>Conditioning, Operant - drug effects</topic><topic>Enkephalin, Ala-MePhe-Gly- - pharmacology</topic><topic>Guanosine 5'-O-(3-Thiotriphosphate) - metabolism</topic><topic>Heroin - pharmacology</topic><topic>Hyperalgesia - drug therapy</topic><topic>Hyperalgesia - psychology</topic><topic>Infusions, Intravenous</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Naltrexone - analogs &amp; derivatives</topic><topic>Naltrexone - pharmacology</topic><topic>Narcotic Antagonists - pharmacology</topic><topic>Peripheral Nerve Injuries</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Reinforcement, Psychology</topic><topic>Self Administration</topic><topic>Spinal Nerves - injuries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MARTIN, Thomas J</creatorcontrib><creatorcontrib>BUECHLER, Nancy L</creatorcontrib><creatorcontrib>KIM, Susy A</creatorcontrib><creatorcontrib>EWAN, Eric E</creatorcontrib><creatorcontrib>RUOYU XIAO</creatorcontrib><creatorcontrib>CHILDERS, Steven R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Anesthesiology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MARTIN, Thomas J</au><au>BUECHLER, Nancy L</au><au>KIM, Susy A</au><au>EWAN, Eric E</au><au>RUOYU XIAO</au><au>CHILDERS, Steven R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Involvement of the Lateral Amygdala in the Antiallodynic and Reinforcing Effects of Heroin in Rats after Peripheral Nerve Injury</atitle><jtitle>Anesthesiology (Philadelphia)</jtitle><addtitle>Anesthesiology</addtitle><date>2011-03-01</date><risdate>2011</risdate><volume>114</volume><issue>3</issue><spage>633</spage><epage>642</epage><pages>633-642</pages><issn>0003-3022</issn><eissn>1528-1175</eissn><coden>ANESAV</coden><abstract>Neuropathic pain alters opioid self-administration in rats. The brain regions altered in the presence of neuropathic pain mediating these differences have not been identified, but likely involve ascending pain pathways interacting with the limbic system. The amygdala is a brain region that integrates noxious stimulation with limbic activity. μ-Opioid receptors were blocked in the amygdala using the irreversible antagonist, β-funaltrexamine, and the antiallodynic and reinforcing effects of heroin were determined in spinal nerve-ligated rats. In addition, the effect of β-funaltrexamine was determined on heroin self-administration in sham-operated rats. β-Funaltrexamine decreased functional activity of μ-opioid receptors by 60 ± 5% (mean ± SD). Irreversible inhibition of μ-opioid receptors in the amygdala significantly attenuated the ability of doses of heroin up to 100 μg/kg to reverse hypersensitivity after spinal nerve ligation. Heroin intake by self-administration in spinal nerve-ligated rats was increased from 5.0 ± 0.3 to 9.9 ± 2.1 infusions/h after administration of 2.5 nmol of β-funaltrexamine in the lateral amygdala, while having no effect in sham-operated animals (5.8 ± 1.6 before, 6.7 ± 0.9 after). The antiallodynic effects of 60 μg/kg heroin were decreased up to 4 days, but self-administration was affected for up to 14 days. μ-Opioid receptors in the lateral amygdala partially meditate heroin's antiallodynic effects and self-administration after peripheral nerve injury. The lack of effect of β-funaltrexamine on heroin self-administration in sham-operated subjects suggests that opioids maintain self-administration through a distinct mechanism in the presence of pain.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>21293255</pmid><doi>10.1097/aln.0b013e318209aba7</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-3022
ispartof Anesthesiology (Philadelphia), 2011-03, Vol.114 (3), p.633-642
issn 0003-3022
1528-1175
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3044784
source HEAL-Link subscriptions: Lippincott Williams & Wilkins
subjects Amygdala - physiology
Analgesics, Opioid - pharmacology
Anesthesia
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Behavior, Animal - drug effects
Biological and medical sciences
Brain - drug effects
Brain - metabolism
Conditioning, Operant - drug effects
Enkephalin, Ala-MePhe-Gly- - pharmacology
Guanosine 5'-O-(3-Thiotriphosphate) - metabolism
Heroin - pharmacology
Hyperalgesia - drug therapy
Hyperalgesia - psychology
Infusions, Intravenous
Male
Medical sciences
Naltrexone - analogs & derivatives
Naltrexone - pharmacology
Narcotic Antagonists - pharmacology
Peripheral Nerve Injuries
Rats
Rats, Inbred F344
Reinforcement, Psychology
Self Administration
Spinal Nerves - injuries
title Involvement of the Lateral Amygdala in the Antiallodynic and Reinforcing Effects of Heroin in Rats after Peripheral Nerve Injury
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A16%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Involvement%20of%20the%20Lateral%20Amygdala%20in%20the%20Antiallodynic%20and%20Reinforcing%20Effects%20of%20Heroin%20in%20Rats%20after%20Peripheral%20Nerve%20Injury&rft.jtitle=Anesthesiology%20(Philadelphia)&rft.au=MARTIN,%20Thomas%20J&rft.date=2011-03-01&rft.volume=114&rft.issue=3&rft.spage=633&rft.epage=642&rft.pages=633-642&rft.issn=0003-3022&rft.eissn=1528-1175&rft.coden=ANESAV&rft_id=info:doi/10.1097/aln.0b013e318209aba7&rft_dat=%3Cproquest_pubme%3E923201779%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c535t-5cd2e15ee6489581b10a28224ccda02763c5c1122c65b457db09f0c05d9c58303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=923201779&rft_id=info:pmid/21293255&rfr_iscdi=true